BiotechTube
Home/Breakthru Medicine/Mark Gergen
MG

Mark Gergen

Board Chair

Breakthru Medicine

Therapeutic Areas

Oncology

Breakthru Medicine Pipeline

DrugIndicationPhase
Lead Program (undisclosed)Aggressive Solid TumorsPre-clinical

Leadership Team at Breakthru Medicine

SP
Steve Potts, PhD, MBA
Chief Executive Officer
MM
Mark Mulvihill, PhD
Chief Science Officer
BB
Brian Barnett, MD
Chief Medical Officer
View full Breakthru Medicine profile